Dr Sumia Bageghni

Research Fellow in Cardiovascular Science
School of Biomedical Sciences

Contact: Garstang, email address for  

Bageghni SA, Hemmings KE, Zava N, Denton CP, Porter KE, Ainscough JFX, Drinkhill MJ, Turner NA Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology fj201701455RR-, 2018
DOI:10.1096/fj.201701455rr
View abstract

Mylonas KJ, Turner NA, Bageghni SA, Kenyon CJ, White CI, McGregor K, Kimmitt RA, Sulston R, Kelly V, Walker BR, Porter KE, Chapman KE, Gray GA 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI Journal of Endocrinology 233 315-327, 2017
DOI:10.1530/JOE-16-0501
View abstract

Ridings-Figueroa R, Stewart ER, Nesterova TB, Coker H, Pintacuda G, Godwin J, Wilson R, Haslam A, Lilley F, Ruigrok R, Bageghni SA, Albadrani G, Mansfield W, Roulson J-A, Brockdorff N, Ainscough JF, Coverley D The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory Genes&Development 31 876-888, 2017
DOI:10.1101/gad.295907.117

Bageghni SA, Frentzou GA, Drinkhill MJ, Mansfield W, Coverley D, Ainscough JFX Cardiomyocyte-specific expression of the nuclear matrix protein, CIZ1, stimulates production of mono-nucleated cells with an extended window of proliferation in the postnatal mouse heart Biology Open 6 92-99, 2017
DOI:10.1242/bio.021550
View abstract

Bageghni SA, Hemmings KE, Porter KE, Ainscough JFX, Drinkhill MJ, Turner NA CARDIAC FIBROBLAST P38 alpha MAP KINASE IS ESSENTIAL FOR CARDIOMYOCYTE HYPERTROPHY AND CARDIAC DYSFUNCTION FOLLOWING MYOCARDIAL INJURY, 2016
DOI:10.1136/heartjnl-2016-310696.4

Bageghni SA, Hemmings KE, Porter KE, Ainscough JF, Drinkhill MJ, Turner NA Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy, 2016

Hemmings KE, Bageghni SA, Pinteaux E, Drinkhill MJ, Turner NA DEVELOPING A TRANSGENIC MOUSE MODEL WITH INDUCIBLE CARDIAC FIBROBLAST-SELECTIVE DELETION OF THE INTERLEUKIN-1 RECEPTOR, IL1R1, 2015
DOI:10.1136/heartjnl-2015-308734.33

Hemmings KE, Bageghni SA, Porter KE, Drinkhill MJ, Ainscough JFX, Turner NA A TRANSGENIC APPROACH TO STUDY THE EFFECT OF CARDIAC FIBROBLAST-SPECIFIC ABLATION OF IL-1 SIGNALLING ON MYOCARDIAL REMODELLING, 2014
DOI:10.1136/heartjnl-2014-306916.58

Sedgwick B, Riches K, Bageghni SA, O'Regan DJ, Porter KE, Turner NA Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and Type 2 diabetic donors. Cardiovasc Pathol 23 204-210, 2014
DOI:10.1016/j.carpath.2014.03.004
View abstract

Bageghni SA, Batten T, Ainscough JF-X Role of the DNA replication protein, Ciz1, in the mammalian cardiomyocyte, 2012